← Evidence map

ArticleBMC urology2021

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer.

Becky A S Bibby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34210300